teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions

reweave: 2026 04 07 #2464

Closed
m3taversal wants to merge 1 commit from reweave/2026-04-07 into main
pull from: reweave/2026-04-07
merge into: teleo:main
Conversation 8 Commits 1 Files changed 30 +118
m3taversal commented 2026-04-07 01:26:09 +00:00
Owner
Copy link
No description provided.
m3taversal added 1 commit 2026-04-07 01:26:10 +00:00 
Threshold: 0.7, Haiku classification, 30 files modified.

Pentagon-Agent: Epimetheus <0144398e-4ed3-4fe2-95a3-3d72e1abf887>
m3taversal commented 2026-04-07 01:26:30 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-07 01:26:52 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-07 01:26 UTC

<!-- TIER0-VALIDATION:4d9fb53f596af413861df08ee8ec0bd13b1696e4 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-07 01:26 UTC*
m3taversal commented 2026-04-07 01:27:22 +00:00
Author
Owner
Copy link

Auto-approved: reweave structural update (frontmatter edges only). Leo reviews manually.

Auto-approved: reweave structural update (frontmatter edges only). Leo reviews manually.
leo commented 2026-04-07 01:27:50 +00:00
Member
Copy link

Eval started — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet)

teleo-eval-orchestrator v2

**Eval started** — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet) *teleo-eval-orchestrator v2*
m3taversal closed this pull request 2026-04-07 01:28:46 +00:00
m3taversal commented 2026-04-07 01:28:46 +00:00
Author
Owner
Copy link

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
leo commented 2026-04-07 01:29:13 +00:00
Member
Copy link

Leo Cross-Domain Review — PR #2464

PR: reweave: connect 19 orphan claims via vector similarity + merge 30 files via frontmatter union
Scope: 30 files across health (22), space-development (6), grand-strategy (1), entities (1)
Nature: Automated reweave — adds supports, related, and reweave_edges frontmatter to existing claims. No claim bodies changed. No new claims.

Issues requiring changes

1. Entity/identifier edges masquerading as claim supports

Three patterns where supports links point to entities or identifiers rather than claim titles:

"Aetherflux" (3 files):

  • breakthrough-energy-ventures-investment-in-orbital-solar-infrastructure-signals-sbsp-credibility-as-climate-technology-category.md
  • orbital-data-centers-and-space-based-solar-power-share-identical-infrastructure-requirements-creating-dual-use-revenue-bridge.md
  • space-based-solar-power-and-orbital-data-centers-share-infrastructure-making-odc-the-near-term-revenue-bridge-to-long-term-sbsp.md

"Aetherflux" is a company name, not a claim. The vector similarity likely matched the entity mention. These edges are semantically meaningless — a claim can't "support" a company.

"UK House of Lords Science and Technology Committee" (1 file):

  • uk-eu-us-clinical-ai-regulation-converged-on-adoption-acceleration-q1-2026.md

Same problem — an entity, not a claim. Also creates a bizarre inversion: a claim "supports" its own source institution.

"NCT07328815 - Mitigating Automation Bias in Physician-LLM Diagnostic Reasoning" (1 file):

  • human-in-the-loop clinical AI degrades to worse-than-AI-alone...md

This is a clinical trial ID, not a claim in the KB. Looks like the vector search matched against source material metadata.

Fix: Remove all 5 of these edges. The reweave pipeline needs a filter that validates targets are actual claim titles (or at minimum, .md files in the KB).

2. Duplicate support entries (dict + string)

Two files already had supports in {'key': 'value'} dict format from a prior reweave. This PR adds the same edge again as a plain string:

  • fda-maude-cannot-identify-ai-contributions-to-adverse-events-due-to-structural-reporting-gaps.md — "The clinical AI safety gap is doubly structural..." appears as both {'The clinical AI safety gap is doubly structural': "FDA enforcement..."} and the plain string version
  • fda-maude-database-lacks-ai-specific-adverse-event-fields-creating-systematic-under-detection-of-ai-attributable-harm.md — same pattern
  • regulatory-deregulation-occurring-during-active-harm-accumulation-not-after-safety-evidence.md — same

Fix: Deduplicate. The plain string format is cleaner — remove the dict-format duplicates while you're at it, or at minimum don't add a second entry for the same semantic edge.

3. Field ordering inconsistency

Several files have related placed after reweave_edges or after supports, creating inconsistent frontmatter ordering across the KB. Example in commercial space stations...md:

reweave_edges:
- ...
related:
- Anchor customer uncertainty...

Minor but worth normalizing. The natural reading order is: supports → related → reweave_edges (edges last, since they're audit metadata).

Observations (non-blocking)

The health regulatory cluster is well-connected. The clinical AI deregulation claims (regulatory vacuum, rollback, convergence, safety gap, MAUDE) form a tight network now. The edges are directionally correct — regulatory-vacuum supports regulatory-rollback, clinical-ai-safety-gap supports both MAUDE claims, etc.

The CVD/UPF causal chain is good. UPF → inflammation → hypertension → CVD bifurcation → healthspan gap — each link in the chain now has explicit supports edges. This is exactly what reweave should produce.

The space cluster edges are weaker. Beyond the Aetherflux entity problem, the "anchor customer uncertainty" edges on the funding-freeze claims are reasonable but the connection is supports when related might be more accurate — a funding freeze is evidence for anchor customer uncertainty, not a logical support of the claim itself.

Cross-domain: The grand-strategy Ottawa Treaty claim getting a new edge to a dual-use AI verification claim is a genuine cross-domain connection worth having.

Verdict: request_changes
Model: opus
Summary: Automated reweave mostly produces valid edges, but 5 edges link to entities/identifiers instead of claims (Aetherflux ×3, UK Lords committee ×1, clinical trial ID ×1) and 3 files have duplicate support entries from format mismatch. Remove the invalid edges and dedup before merge.

# Leo Cross-Domain Review — PR #2464 **PR:** reweave: connect 19 orphan claims via vector similarity + merge 30 files via frontmatter union **Scope:** 30 files across health (22), space-development (6), grand-strategy (1), entities (1) **Nature:** Automated reweave — adds `supports`, `related`, and `reweave_edges` frontmatter to existing claims. No claim bodies changed. No new claims. --- ## Issues requiring changes ### 1. Entity/identifier edges masquerading as claim supports Three patterns where `supports` links point to entities or identifiers rather than claim titles: **"Aetherflux" (3 files):** - `breakthrough-energy-ventures-investment-in-orbital-solar-infrastructure-signals-sbsp-credibility-as-climate-technology-category.md` - `orbital-data-centers-and-space-based-solar-power-share-identical-infrastructure-requirements-creating-dual-use-revenue-bridge.md` - `space-based-solar-power-and-orbital-data-centers-share-infrastructure-making-odc-the-near-term-revenue-bridge-to-long-term-sbsp.md` "Aetherflux" is a company name, not a claim. The vector similarity likely matched the entity mention. These edges are semantically meaningless — a claim can't "support" a company. **"UK House of Lords Science and Technology Committee" (1 file):** - `uk-eu-us-clinical-ai-regulation-converged-on-adoption-acceleration-q1-2026.md` Same problem — an entity, not a claim. Also creates a bizarre inversion: a claim "supports" its own source institution. **"NCT07328815 - Mitigating Automation Bias in Physician-LLM Diagnostic Reasoning" (1 file):** - `human-in-the-loop clinical AI degrades to worse-than-AI-alone...md` This is a clinical trial ID, not a claim in the KB. Looks like the vector search matched against source material metadata. **Fix:** Remove all 5 of these edges. The reweave pipeline needs a filter that validates targets are actual claim titles (or at minimum, `.md` files in the KB). ### 2. Duplicate support entries (dict + string) Two files already had supports in `{'key': 'value'}` dict format from a prior reweave. This PR adds the same edge again as a plain string: - `fda-maude-cannot-identify-ai-contributions-to-adverse-events-due-to-structural-reporting-gaps.md` — "The clinical AI safety gap is doubly structural..." appears as both `{'The clinical AI safety gap is doubly structural': "FDA enforcement..."}` and the plain string version - `fda-maude-database-lacks-ai-specific-adverse-event-fields-creating-systematic-under-detection-of-ai-attributable-harm.md` — same pattern - `regulatory-deregulation-occurring-during-active-harm-accumulation-not-after-safety-evidence.md` — same **Fix:** Deduplicate. The plain string format is cleaner — remove the dict-format duplicates while you're at it, or at minimum don't add a second entry for the same semantic edge. ### 3. Field ordering inconsistency Several files have `related` placed after `reweave_edges` or after `supports`, creating inconsistent frontmatter ordering across the KB. Example in `commercial space stations...md`: ```yaml reweave_edges: - ... related: - Anchor customer uncertainty... ``` Minor but worth normalizing. The natural reading order is: `supports` → `related` → `reweave_edges` (edges last, since they're audit metadata). ## Observations (non-blocking) **The health regulatory cluster is well-connected.** The clinical AI deregulation claims (regulatory vacuum, rollback, convergence, safety gap, MAUDE) form a tight network now. The edges are directionally correct — `regulatory-vacuum` supports `regulatory-rollback`, `clinical-ai-safety-gap` supports both MAUDE claims, etc. **The CVD/UPF causal chain is good.** UPF → inflammation → hypertension → CVD bifurcation → healthspan gap — each link in the chain now has explicit `supports` edges. This is exactly what reweave should produce. **The space cluster edges are weaker.** Beyond the Aetherflux entity problem, the "anchor customer uncertainty" edges on the funding-freeze claims are reasonable but the connection is `supports` when `related` might be more accurate — a funding freeze is evidence *for* anchor customer uncertainty, not a logical support of the claim itself. **Cross-domain:** The grand-strategy Ottawa Treaty claim getting a new edge to a dual-use AI verification claim is a genuine cross-domain connection worth having. --- **Verdict:** request_changes **Model:** opus **Summary:** Automated reweave mostly produces valid edges, but 5 edges link to entities/identifiers instead of claims (Aetherflux ×3, UK Lords committee ×1, clinical trial ID ×1) and 3 files have duplicate support entries from format mismatch. Remove the invalid edges and dedup before merge. <!-- VERDICT:LEO:REQUEST_CHANGES -->
vida commented 2026-04-07 01:36:32 +00:00
Member
Copy link

Vida Domain Peer Review — PR #2464

Reweave: connect 19 orphan claims via vector similarity / merge 42 files via frontmatter union

What this PR actually does

This is a reweave PR, not a new-claims PR. It adds supports, related, and reweave_edges frontmatter to 22 existing health claims, connecting them to each other and to claims in adjacent clusters. No new claim content is being created — the underlying arguments were already in main.

Reweave connection quality

All examined connections are semantically correct from a health domain perspective:

CVD cluster: The new edge from hypertension-shifted-from-secondary-to-primary-cvd-mortality-driver-since-2022 to the heart failure mortality baseline reversal is a legitimate mechanistic link — better acute ischemic care creating a larger pool of HF survivors who then contribute to the chronic disease burden. The bidirectional support between us-healthspan-declining and us-healthspan-lifespan-gap-largest-globally is appropriately directional (declining healthspan supports the gap claim, not the reverse). The us-healthcare-ranks-last → healthspan gap edge is valid: the ranking is downstream evidence of the structural failure the gap measures.

UPF cluster: Connecting upf-driven-chronic-inflammation-explains-antihypertensive-failure back to ultra-processed-food-increases-incident-hypertension via the 23% risk increase is correct — the mechanism claim should support the incidence claim that motivated it.

Clinical AI regulatory cluster: The three-way connection among regulatory-rollback, regulatory-vacuum, and uk-eu-us-clinical-ai-regulation-converged-on-adoption-acceleration is exactly right. These three claims form a coherent evidence chain about Q1 2026 regulatory trajectory and should be mutually linked. The additional edges from regulatory-deregulation-occurring-during-active-harm-accumulation to the doubly-structural safety gap and rollback claims are valid.

Multi-agent AI: The edge from multi-agent-clinical-ai-reduces-computational-cost-65x to multi-agent-adoption-driven-by-efficiency-not-safety correctly captures the dependency — the 65x efficiency gain is the mechanism that drives adoption-for-efficiency, which then creates the accidental harm reduction pathway.

Digital health disparities: The related edge to tailored digital interventions achieving clinically significant BP reductions is the right contrast — the point is that generic deployment fails while targeted design succeeds. This is a valid bidirectional relationship.

Issue requiring attention

Pre-existing Python dict artifact not cleaned up (regulatory-deregulation-occurring-during-active-harm-accumulation-not-after-safety-evidence.md)

This file had a serialization bug before this PR, where a supports entry was stored as a Python dict literal rather than a plain string:

- {'The clinical AI safety gap is doubly structural': "FDA enforcement discretion removes..."}

This PR correctly added the properly formatted version on the next line, but left the broken entry in place. In the reweave_edges block, the broken version includes the pipe delimiter inside the quoted value, which would prevent any parser from extracting the edge metadata correctly:

- {'The clinical AI safety gap is doubly structural': "FDA enforcement...removes post-market surveillance cannot detect AI-attributable harm|supports|2026-04-07"}

YAML will parse {...} as a flow mapping within the sequence — so a consumer expecting all supports entries to be strings gets a mixed-type list. Since this file is already being edited in this PR, the broken entries (lines 16 and 23 in the current file) should be removed here rather than left for a separate cleanup pass.

Missed connection worth flagging

The body of upf-driven-chronic-inflammation-explains-antihypertensive-treatment-failure explicitly describes GLP-1's anti-inflammatory pathway as working in the opposite direction of UPF-driven inflammation:

"The GLP-1 receptor agonist anti-inflammatory pathway (hsCRP reduction) provides complementary evidence: semaglutide's cardiovascular benefit is 67% independent of weight loss, operating primarily through inflammation reduction—the same inflammatory mechanism that UPF drives in the opposite direction."

This is the most interesting mechanistic cross-connection in the health domain: UPF continuously regenerates the inflammatory burden that GLP-1 reduces. The claim semaglutide-cardiovascular-benefit-is-67-percent-independent-of-weight-loss-with-inflammation-as-primary-mediator already exists in the KB. A related edge between these two claims would make this mechanistic inverse relationship navigable. Worth adding either in this PR or flagging for next reweave pass.

Minor observations

Hypertension confidence calibration is fine. The claim uses "primary contributing cardiovascular cause of death" throughout the body text, which is technically correct — the AHA 2026 Statistics Update shows hypertension surpassed ischemic heart disease as a contributing cause, not an underlying cause. Confidence proven against AHA 2026 data is justified.

76.6% antihypertensive treatment failure attribution is appropriately hedged. The source explicitly says "inferential connection" between the REGARDS cohort mechanism and the treatment failure epidemiology. The experimental confidence captures this accurately. The title is assertive but the body qualifies it.

The Theseus connection is real and should be noted. The clinical AI HITL degradation, regulatory vacuum, and automation bias cluster here maps directly onto Theseus's alignment domain (de-skilling and automation bias as alignment failure modes in high-stakes settings). This cross-domain signal is already present in existing claims but the reweave doesn't surface it. Not a blocking concern — just worth flagging for coordination.

Verdict: request_changes
Model: sonnet
Summary: All 22 health claim connections are semantically correct and directionally valid. One blocking issue: the pre-existing Python dict artifact in regulatory-deregulation-occurring-during-active-harm-accumulation-not-after-safety-evidence.md (lines 16 and 23) must be removed since this PR is already editing that file — leaving the broken YAML alongside the correct version creates a mixed-type sequence. Separately worth adding: a related edge from the UPF antihypertensive failure claim to semaglutide-cardiovascular-benefit-is-67-percent-independent-of-weight-loss to surface the mechanistic inverse relationship already described in the claim body.

# Vida Domain Peer Review — PR #2464 *Reweave: connect 19 orphan claims via vector similarity / merge 42 files via frontmatter union* ## What this PR actually does This is a reweave PR, not a new-claims PR. It adds `supports`, `related`, and `reweave_edges` frontmatter to 22 existing health claims, connecting them to each other and to claims in adjacent clusters. No new claim content is being created — the underlying arguments were already in main. --- ## Reweave connection quality All examined connections are semantically correct from a health domain perspective: **CVD cluster:** The new edge from `hypertension-shifted-from-secondary-to-primary-cvd-mortality-driver-since-2022` to the heart failure mortality baseline reversal is a legitimate mechanistic link — better acute ischemic care creating a larger pool of HF survivors who then contribute to the chronic disease burden. The bidirectional support between `us-healthspan-declining` and `us-healthspan-lifespan-gap-largest-globally` is appropriately directional (declining healthspan supports the gap claim, not the reverse). The `us-healthcare-ranks-last` → healthspan gap edge is valid: the ranking is downstream evidence of the structural failure the gap measures. **UPF cluster:** Connecting `upf-driven-chronic-inflammation-explains-antihypertensive-failure` back to `ultra-processed-food-increases-incident-hypertension` via the 23% risk increase is correct — the mechanism claim should support the incidence claim that motivated it. **Clinical AI regulatory cluster:** The three-way connection among `regulatory-rollback`, `regulatory-vacuum`, and `uk-eu-us-clinical-ai-regulation-converged-on-adoption-acceleration` is exactly right. These three claims form a coherent evidence chain about Q1 2026 regulatory trajectory and should be mutually linked. The additional edges from `regulatory-deregulation-occurring-during-active-harm-accumulation` to the doubly-structural safety gap and rollback claims are valid. **Multi-agent AI:** The edge from `multi-agent-clinical-ai-reduces-computational-cost-65x` to `multi-agent-adoption-driven-by-efficiency-not-safety` correctly captures the dependency — the 65x efficiency gain is the mechanism that drives adoption-for-efficiency, which then creates the accidental harm reduction pathway. **Digital health disparities:** The `related` edge to tailored digital interventions achieving clinically significant BP reductions is the right contrast — the point is that generic deployment fails while targeted design succeeds. This is a valid bidirectional relationship. --- ## Issue requiring attention **Pre-existing Python dict artifact not cleaned up** (`regulatory-deregulation-occurring-during-active-harm-accumulation-not-after-safety-evidence.md`) This file had a serialization bug before this PR, where a `supports` entry was stored as a Python dict literal rather than a plain string: ```yaml - {'The clinical AI safety gap is doubly structural': "FDA enforcement discretion removes..."} ``` This PR correctly added the properly formatted version on the next line, but left the broken entry in place. In the `reweave_edges` block, the broken version includes the pipe delimiter *inside* the quoted value, which would prevent any parser from extracting the edge metadata correctly: ```yaml - {'The clinical AI safety gap is doubly structural': "FDA enforcement...removes post-market surveillance cannot detect AI-attributable harm|supports|2026-04-07"} ``` YAML will parse `{...}` as a flow mapping within the sequence — so a consumer expecting all `supports` entries to be strings gets a mixed-type list. Since this file is already being edited in this PR, the broken entries (lines 16 and 23 in the current file) should be removed here rather than left for a separate cleanup pass. --- ## Missed connection worth flagging The body of `upf-driven-chronic-inflammation-explains-antihypertensive-treatment-failure` explicitly describes GLP-1's anti-inflammatory pathway as working in the opposite direction of UPF-driven inflammation: > "The GLP-1 receptor agonist anti-inflammatory pathway (hsCRP reduction) provides complementary evidence: semaglutide's cardiovascular benefit is 67% independent of weight loss, operating primarily through inflammation reduction—the same inflammatory mechanism that UPF drives in the opposite direction." This is the most interesting mechanistic cross-connection in the health domain: UPF continuously regenerates the inflammatory burden that GLP-1 reduces. The claim `semaglutide-cardiovascular-benefit-is-67-percent-independent-of-weight-loss-with-inflammation-as-primary-mediator` already exists in the KB. A `related` edge between these two claims would make this mechanistic inverse relationship navigable. Worth adding either in this PR or flagging for next reweave pass. --- ## Minor observations **Hypertension confidence calibration is fine.** The claim uses "primary contributing cardiovascular cause of death" throughout the body text, which is technically correct — the AHA 2026 Statistics Update shows hypertension surpassed ischemic heart disease as a *contributing* cause, not an *underlying* cause. Confidence `proven` against AHA 2026 data is justified. **76.6% antihypertensive treatment failure attribution is appropriately hedged.** The source explicitly says "inferential connection" between the REGARDS cohort mechanism and the treatment failure epidemiology. The `experimental` confidence captures this accurately. The title is assertive but the body qualifies it. **The Theseus connection is real and should be noted.** The clinical AI HITL degradation, regulatory vacuum, and automation bias cluster here maps directly onto Theseus's alignment domain (de-skilling and automation bias as alignment failure modes in high-stakes settings). This cross-domain signal is already present in existing claims but the reweave doesn't surface it. Not a blocking concern — just worth flagging for coordination. --- **Verdict:** request_changes **Model:** sonnet **Summary:** All 22 health claim connections are semantically correct and directionally valid. One blocking issue: the pre-existing Python dict artifact in `regulatory-deregulation-occurring-during-active-harm-accumulation-not-after-safety-evidence.md` (lines 16 and 23) must be removed since this PR is already editing that file — leaving the broken YAML alongside the correct version creates a mixed-type sequence. Separately worth adding: a `related` edge from the UPF antihypertensive failure claim to `semaglutide-cardiovascular-benefit-is-67-percent-independent-of-weight-loss` to surface the mechanistic inverse relationship already described in the claim body. <!-- VERDICT:VIDA:REQUEST_CHANGES -->
leo commented 2026-04-07 01:36:32 +00:00
Member
Copy link

Changes requested by leo(cross-domain), vida(domain-peer). Address feedback and push to trigger re-eval.

teleo-eval-orchestrator v2

**Changes requested** by leo(cross-domain), vida(domain-peer). Address feedback and push to trigger re-eval. *teleo-eval-orchestrator v2*

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#2464
No description provided.
Delete branch "reweave/2026-04-07"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?